Search results for "obstetric"

showing 10 items of 2144 documents

Maternal serum ghrelin levels in early IVF pregnancies: lack of prognostic value for viable pregnancy and altered post-prandial responses

2008

Background Ghrelin is a pleiotropic hormone, involved in the control of growth and metabolism, whose circulating levels fluctuate in relation to food intake and body mass index. Ghrelin has been detected in the decidualized endometrium, as well as in human and rat placenta. Methods A total of 106 patients undergoing IVF procedures were prospectively recruited. On Days 16 and 23 after oocyte retrieval, the patients were subjected to blood sampling after overnight fasting, for determination of serum ghrelin, hCGbeta and progesterone levels. In addition, ghrelin levels were assayed in these groups, 2 h after ingestion of a fixed-calorie meal. Results The subjects were divided according to whet…

Adultmedicine.medical_specialtyFertilization in VitroBiologyEndometriumBody Mass IndexPregnancyInternal medicinemedicineHumansIngestionChorionic Gonadotropin beta Subunit HumanProspective StudiesProgesteronePregnancydigestive oral and skin physiologyRehabilitationPregnancy OutcomeObstetrics and GynecologyGestational ageFastingPostprandial PeriodPrognosismedicine.diseaseGhrelinEndocrinologymedicine.anatomical_structurePostprandialReproductive MedicineFemaleGhrelinhormones hormone substitutes and hormone antagonistsBlood samplingHormoneHuman Reproduction
researchProduct

CARDIAC PUNCTURE OF FETUS WITH HURLER'S DISEASE AVOIDING ABORTION OF UNAFFECTED CO-TWIN

1978

Adultmedicine.medical_specialtyFetal ResorptionMucopolysaccharidosis IFetal heartPuncturesDiseaseAbortionIduronidaseFetal HeartPregnancyPrenatal DiagnosisDiseases in TwinsHumansMedicineFetal DeathGlucuronidaseGlycosaminoglycansFetusPregnancyFetal deathbusiness.industryObstetricsInfant NewbornFollow up studiesInfantFetal ResorptionGeneral MedicineFibroblastsAmniotic Fluidbeta-Galactosidasemedicine.diseaseAnesthesiaFemalebusinessFollow-Up StudiesThe Lancet
researchProduct

Prenatal Exposure to Polybrominated Flame Retardants and Fetal Growth in the INMA Cohort (Spain)

2015

Our aim was to investigate the relation between PBDEs and fetal growth or newborn anthropometry in a Spanish cohort (2003-2008). PBDE congeners (BDE-47, -99, -153, -154, and -209) were determined in serum of 670 mothers at gestational week 12 and in 534 umbilical cord samples. Abdominal circumference (AC), estimated fetal weight (EFW), femur length (FL), and biparietal diameter (BPD) during gestation were measured by ultrasounds. At birth, weight (BW), head circumference (HC), and length (BL) were also measured. We assessed growth in the intervals between 12-20 and 20-34 weeks of gestation and size at birth by standard deviation (SD)-scores adjusted for constitutional characteristics. We co…

Adultmedicine.medical_specialtyFetal monitoring010501 environmental sciences01 natural sciencesUmbilical cordFlame retardantsArticleUltrasonography PrenatalCohort StudiesFetal Development03 medical and health sciences0302 clinical medicinePregnancyBayesian multivariate linear regressionInternal medicinePrenatal exposureHalogenated Diphenyl EthersmedicineFetal growthBody SizeHumansEnvironmental ChemistryPregnancy exposome030212 general & internal medicine0105 earth and related environmental sciencesPregnancyObstetricsbusiness.industryBody WeightInfant NewbornGeneral ChemistryAnthropometrymedicine.disease3. Good healthEndocrinologymedicine.anatomical_structureSpainPrenatal Exposure Delayed EffectsCohortGestationFemalebusinessCohort study
researchProduct

Selected food intake and risk of endometriosis.

2004

Background: To offer data on the relationship between diet and risk of pelvic endometriosis, we analysed data collected in the framework of two case-control studies. Methods: Data from two case-control studies conducted in Northern Italy between 1984 and 1999 were combined. Cases were 504 women aged < 65 years (median age 33 years, range 20-65) with a laparoscopically confirmed diagnosis of endometriosis, admitted to a network of obstetrics and gynaecology departments in Milan, Brescia and Pavia. Controls were 504 women (median age 34 years, range 20-61) admitted for acute non-gynaecological, non-hormonal, non-neoplastic conditions. Results: Compared to women in the lowest tertile of intake…

Adultmedicine.medical_specialtyFood intakeMeatPhysiologyCase-control study; Endometriosis; Risk factorsEndometriosisEndometriosisVegetableEatingObstetrics and gynaecologyRisk FactorsVegetablesmedicineHumansRisk factorEndometriosiGynecologyPelvic endometriosisObstetricsbusiness.industryRisk FactorRehabilitationCase-control studyObstetrics and GynecologyNutrition SurveyCase-control studyOdds ratioMiddle Agedmedicine.diseaseNutrition SurveysDietReproductive MedicineItalyFoodCase-Control StudiesFruitRed meatFemalebusinessCase-Control StudieHumanDevelopmental BiologyHuman reproduction (Oxford, England)
researchProduct

Preimplantation genetic diagnosis by fluorescence in situ hybridization: clinical possibilities and pitfalls.

2003

Preimplantation genetic diagnosis using the fluorescence in situ hybridization technique (FISH) is being used widely to prevent the transmission of sex-linked diseases, to screen for translocations, and for aneuploidy screenng in specific invitro fertilization (IVF) patient groups, along with FISH analysis of spematozoa in intertile men. In this study, we aim to critically analyze our clinical results in patients at risk of transmitting sex-linked diseases (n = 55), in carriers of translocations (n = 43), in women who have recurent miscarriage (two or more miscarriages) (n = 128), recurrent IVF failure (three or more failed IVF attempts) (n = 47), and patients of advanced maternal age (37 y…

Adultmedicine.medical_specialtyGenetic LinkagePregnancy High-RiskAneuploidyFertilization in VitroBiologyPreimplantation genetic diagnosisTranslocation GeneticMiscarriageRecurrent miscarriagemedicineHumansAdvanced maternal ageTreatment FailureIn Situ Hybridization FluorescencePreimplantation DiagnosisGynecologyPregnancySex Chromosomesmedicine.diagnostic_testIncidence (epidemiology)Genetic Diseases InbornObstetrics and Gynecologymedicine.diseaseAbortion SpontaneousFemaleFluorescence in situ hybridizationMaternal AgeJournal of the Society for Gynecologic Investigation
researchProduct

A questionnaire assessing women's care needs related to gynaecological cancer screening: development of the GCSCNS.

2013

Abstract Objective To identify women's care needs concerning cancer screening and to develop an instrument suitable for measuring them – the Gynaecological Cancer Screening Care Needs Scale (GCSCNS). We hypothesized that it is possible: (a) to explore care needs and to develop reliable subscales of them, (b) to rank these needs in order of importance, and (c) to detect determinants of these needs (age, social status, marital status, health locus of control) and these need scores. Study design A questionnaire was developed based on the relevant literature, interviews conducted with gynaecological patients, and a consultation with 18 experts. The questionnaire listed 58 items addressed to phy…

Adultmedicine.medical_specialtyGenital Neoplasms FemaleVarimax rotationPhysical examinationYoung AdultCronbach's alphaSurveys and QuestionnairesCancer screeningmedicineHumansMass ScreeningPsychiatryInternal-External ControlAgedAged 80 and overDescriptive statisticsmedicine.diagnostic_testbusiness.industryAge FactorsObstetrics and GynecologyMiddle AgedLocus of controlCross-Sectional StudiesReproductive MedicineSocioeconomic FactorsFamily medicineMarital statusFemalebusinessDelivery of Health CareSocial statusEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients

1992

CORT is a new radiosurgical treatment concept for patients with recurrent gynecologic malignancies infiltrating the pelvic wall. The operative part consists of (i) staging laparotomy; (ii) maximum debulking of the tumor from the pelvic wall and exenteration of infiltrated central pelvic organs; (iii) implantation of brachytherapy guiding tubes on the residual tumor/tumor bed at the pelvic wall; (iv) pelvic wall plasty with muscle and omentum flaps to create a protective distance between the tubes and the pelvic hollow organs and to induce therapeutic angiogenesis; and (v) surgical reconstruction of bowel, bladder, and vulvoperineovaginal functions. Radiation is given postoperatively as frac…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentBrachytherapyBrachytherapyWhole-PelvisPelvic wallHumansMedicineProspective StudiesPelvic NeoplasmsPelvic organbusiness.industryPrior RadiationOperative mortalityObstetrics and GynecologyRadiotherapy DosageGeneral MedicineMiddle AgedPrognosisDebulkingCombined Modality TherapySurgeryRadiation therapyOncologyFemalebusinessPelvic radiotherapyInternational Journal of Gynecology &amp; Obstetrics
researchProduct

Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients.

2013

ObjectiveOur study purpose was to evaluate morbidity and postoperative mortality in patients who underwent pelvic exenteration (PE) for primary or recurrent gynecological malignancies.MethodsWe identified 230 patients who underwent PE, referred to the gynecological oncology units of 4 institutions: Charitè University in Berlin, Friedrich-Schiller University in Jena, S. Orsola-Malpighi University in Bologna, and Catholic University in Rome and in Campobasso.ResultsThe median age was 55 years. The tumor site was the cervix in 177 patients, the endometrium in 28 patients, the vulva in 16 patients, and the vagina in 9 patients. Sixty-eight anterior, 31 posterior, and 131 total PEs were performe…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentYoung AdultRetrospective StudieGermanymedicineHumansPostoperative PeriodMortalityAgedRetrospective StudiesAged 80 and overCervical cancerVaginal cancerHysterectomyGynecological malignanciePelvic exenterationbusiness.industryEndometrial cancerMortality rateGynecological malignanciesObstetrics and GynecologyPerioperativeMiddle AgedVulvar cancermedicine.diseaseSurvival AnalysisPelvic ExenterationSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAItalyOncologyFemaleSurvival AnalysiMorbidityMorbidity pelvic exenteration gynecological malignanciesbusinessHuman
researchProduct

Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies

2020

ObjectivesPelvic side wall infiltration by gynecological malignancies has been considered for a long time an absolute contraindication to curative resection. The development of the laterally extended endopelvic resection (LEER) has challenged this surgical paradigm. Although the LEER has been standardized in open surgery, only small studies have been published about its endoscopic feasibility. The objective of this study is to analyze the safety of LEER in patients with gynecological malignancies involving the pelvic side wall.MethodsWe retrospectively evaluated a consecutive series of patients who underwent a laparoscopically modified LEER between July 2014 and November 2018. This indicate…

Adultmedicine.medical_specialtyGenital Neoplasms Femalemedicine.medical_treatmentgenital neoplasmRectumPelvissurgical oncologyGynecologic Surgical ProcedureslaparoscopeMedicineHumansHemoperitoneumHydronephrosisContraindicationPelvisAgedRetrospective Studiesbusiness.industryUrinary retentiongynecologyObstetrics and GynecologypelviMiddle Agedmedicine.diseaseSurgerylaparoscopesSettore MED/40 - GINECOLOGIA E OSTETRICIAmedicine.anatomical_structurefemaleOncologygenital neoplasmsConcomitantNephrostomysurgical oncology.Laparoscopymedicine.symptombusiness
researchProduct

Pregnancy outcomes in women with advanced HIV infection in Italy

2011

Pregnancy has been associated with a low risk of HIV disease progression. Most pregnancies with HIV currently involve women who have not experienced AIDS-defining events, and are clinically classified as Centers for Disease Control and Prevention (CDC) groups A or B. We evaluated the main maternal outcomes among pregnant women with more advanced HIV disease, defined by CDC-C disease stage. Data from the Italian National Program on Surveillance on Antiretroviral Treatment in Pregnancy were used. A total of 566 HIV-infected mothers, 515 in stage A or B (CDC-AB group) and 51 in stage C (CDC-C group) were evaluated. The two groups had similar baseline characteristics. No differences were found …

Adultmedicine.medical_specialtyGestational AgeHIV InfectionsDiseaseSettore MED/17 - MALATTIE INFETTIVESeverity of Illness IndexYoung AdultAcquired immunodeficiency syndrome (AIDS)ANTIRETROVIRAL THERAPYRisk FactorsPregnancyAntiretroviral Therapy Highly ActiveSeverity of illnessmedicineHumansPregnancy Complications InfectiousYoung adultPregnancyObstetricsbusiness.industryClinical and Epidemiologic ResearchPregnancy OutcomePublic Health Environmental and Occupational HealthHIVGestational ageLiterMiddle AgedViral Loadmedicine.diseaseinfectionCD4 Lymphocyte CountLogistic ModelsInfectious DiseasesAnti-Retroviral AgentsItalyImmunologyHUMAN-IMMUNODEFICIENCY-VIRUSDisease ProgressionFemalebusinessViral load
researchProduct